Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

ADAMIS PHARMS CO

NASDAQ: ADMPHealthcare / Drug Delivery / USA
4.3500.00Vol 265 1841Y Perf 14.47%
May 25th, 2018 16:00
BID4.30 ASK4.35
Open4.30 Previous Close4.35
Pre-Market- After-Trading4.35
 - -%  - -%
Target Price
7.41 
Analyst Rating
Strong Buy 1.25
Potencial %
70.34 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)145 
Earnings Rating
Price Range Ratio 52wk %
48.78 
Earnings Date

Today's Price Range

4.254.35

 

52wk Range

2.356.45

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
24.29%
3 Months
38.10%
6 Months
3.57%
1 Year
14.47%
3 Years
6.88%
5 Years
-63.45%
Last Quotes
Name / TickerPriceChg.Chg.%
ADMP4.350.00000.00
AAPL188.580.43000.23
GOOG1 075.66-3.5800-0.33
MSFT98.360.05000.05
XOM78.71-1.5600-1.94
WFC54.900.23000.42
JNJ121.470.12000.10
FB184.92-1.0100-0.54
GE14.630.03000.21
JPM110.66-0.5700-0.51
...

TickerPriceChg.%52 Week High
FL55.7420.1660.64
DGX105.814.88112.96
LH182.143.84184.33
LEN53.393.7572.17
ALK61.873.3495.75
LUV52.863.2266.99
AAL44.913.1059.08
RCL109.802.91135.65
K65.232.7174.28
DAL55.872.7060.79
AVGO250.032.67285.68
UA18.882.6621.81
INCY68.432.64140.11
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 1.40
Current Ratio 1.90
Long Term Debt to Total Capital 0.07
Total Debt to Equity 0.15
Interest Coverage -128.30
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin40.80
EBIT Margin-208.20
EBITDA Margin-185.10
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 4.69
PS Ratios 11.88
Price to Cash Flow -
Price to Free Cash Flow -7.20
Cash Flow Per Share -0.63
Price to Tangible Book14.61
Book Value per Share1.00
Enterprise Value (in ths.)152 827
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-108.96
ROE last 12 Months -100.81
Return on Assets (5Y Avg) -40.76
ROA last 12 Months -70.69
Return on Capital (5Y Avg) -
ROC last 12 Months -82.06
Return on invested Capital Q -18.33
Return on invested Capital Y-65.75
Assets Turnover0.10
Receivables Turnover6.10
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)13 215
Revenue per Share 0.40
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2018-0.17-0.23-35.29
Q04 2017--0.24-
Q02 2017--0.19-
Q01 2017-0.21-0.26-23.81
Q04 2016--0.48-
Q02 2016--0.37-
Q04 2015--0.32-
Q03 2015--0.24-
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.18-28.57Negative
9/2018 QR-0.1611.11Positive
12/2018 FY-0.74-15.63Negative
12/2019 FY-0.4521.05Positive
Next Report Date11th May 2018
Estimated EPS Next Report-0.17
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume265 184
Shares Outstanding (in ths.)33 390
Trades Count538
Dollar Volume1 077 857
Avg. Volume660 305
Avg. Weekly Volume480 594
Avg. Monthly Volume548 044
Avg. Quarterly Volume583 817

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

76%24%

Bearish Bullish

66%34%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (75.00 %)
2 (66.67 %)
1 (50.00 %)
Moderate Buy
1 (25.00 %)
1 (33.33 %)
1 (50.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.25
Strong Buy
1.33
Strong Buy
1.50

There are no comments yet.

News

x